Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.

Molecular oncology

Triulzi T, Bianchini G, Di Cosimo S, Pienkowski T, Im YH, Bianchi GV, Galbardi B, Dugo M, De Cecco L, Tseng LM, Liu MC, Bermejo B, Semiglazov V, Viale G, de la Haba-Rodriguez J, Oh DY, Poirier B, Valagussa P, Gianni L, Tagliabue E.
PMID: 34816585
Mol Oncol. 2021 Nov 23; doi: 10.1002/1878-0261.13141. Epub 2021 Nov 23.

As most erb-b2 receptor tyrosine kinase 2 (HER2)-positive breast cancer (BC) patients currently receive dual HER2-targeting added to neoadjuvant chemotherapy, improved methods for identifying individual response, and assisting postsurgical salvage therapy, are needed. Herein, we evaluated the 41-gene classifier...

Cite
Triulzi T, Bianchini G, Di Cosimo S, et al. The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial. Mol Oncol. 2021;doi: 10.1002/1878-0261.13141.
Triulzi, T., Bianchini, G., Di Cosimo, S., Pienkowski, T., Im, Y. H., Bianchi, G. V., Galbardi, B., Dugo, M., De Cecco, L., Tseng, L. M., Liu, M. C., Bermejo, B., Semiglazov, V., Viale, G., de la Haba-Rodriguez, J., Oh, D. Y., Poirier, B., Valagussa, P., Gianni, L., & Tagliabue, E. (2021). The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial. Molecular oncology, . https://doi.org/10.1002/1878-0261.13141
Triulzi, Tiziana, et al. "The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial." Molecular oncology vol. (2021). doi: https://doi.org/10.1002/1878-0261.13141
Triulzi T, Bianchini G, Di Cosimo S, Pienkowski T, Im YH, Bianchi GV, Galbardi B, Dugo M, De Cecco L, Tseng LM, Liu MC, Bermejo B, Semiglazov V, Viale G, de la Haba-Rodriguez J, Oh DY, Poirier B, Valagussa P, Gianni L, Tagliabue E. The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial. Mol Oncol. 2021 Nov 23; doi: 10.1002/1878-0261.13141. Epub 2021 Nov 23. PMID: 34816585.
Copy Download .nbib Format: NLM
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.

Molecular oncology

Triulzi T, Bianchini G, Di Cosimo S, Pienkowski T, Im YH, Valeria Bianchi G, Galbardi B, Dugo M, De Cecco L, Tseng LM, Liu MC, Bermejo B, Semiglazov V, Viale G, de la Haba-Rodriguez J, Oh DY, Poirier B, Valagussa P, Gianni L, Tagliabue E.
PMID: 34816585
Mol Oncol. 2021 Nov 23; doi: 10.1002/1878-0261.13141. Epub 2021 Nov 23.

As most erb-b2 receptor tyrosine kinase 2 (HER2)-positive breast cancer (BC) patients currently receive dual HER2-targeting added to neoadjuvant chemotherapy, improved methods for identifying individual response, and assisting post-surgical salvage therapy, are needed. Herein, we evaluated the 41-gene classifier...

Cite
Triulzi T, Bianchini G, Di Cosimo S, et al. The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial. Mol Oncol. 2021;doi: 10.1002/1878-0261.13141.
Triulzi, T., Bianchini, G., Di Cosimo, S., Pienkowski, T., Im, Y. H., Valeria Bianchi, G., Galbardi, B., Dugo, M., De Cecco, L., Tseng, L. M., Liu, M. C., Bermejo, B., Semiglazov, V., Viale, G., de la Haba-Rodriguez, J., Oh, D. Y., Poirier, B., Valagussa, P., Gianni, L., & Tagliabue, E. (2021). The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial. Molecular oncology, . https://doi.org/10.1002/1878-0261.13141
Triulzi, Tiziana, et al. "The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial." Molecular oncology vol. (2021). doi: https://doi.org/10.1002/1878-0261.13141
Triulzi T, Bianchini G, Di Cosimo S, Pienkowski T, Im YH, Valeria Bianchi G, Galbardi B, Dugo M, De Cecco L, Tseng LM, Liu MC, Bermejo B, Semiglazov V, Viale G, de la Haba-Rodriguez J, Oh DY, Poirier B, Valagussa P, Gianni L, Tagliabue E. The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial. Mol Oncol. 2021 Nov 23; doi: 10.1002/1878-0261.13141. Epub 2021 Nov 23. PMID: 34816585.
Copy Download .nbib Format: NLM
Clinically useful measures to assess the effectiveness of treatments: hints for a proper choice with special emphasis on cancer research.

Tumori

Boracchi P, Mezzanotte G, Mariani L, Valagussa P, Marubini E.
PMID: 2321266
Tumori. 1990 Feb 28;76(1):1-9.

Several absolute and relative measures useful to assess the consequences of treatments in cancer research are presented together with statistical methods suitable for computing the pertinent confidence intervals. The relationship of these measures with the parameters of the regression...

Cite
Boracchi P, Mezzanotte G, Mariani L, et al. Clinically useful measures to assess the effectiveness of treatments: hints for a proper choice with special emphasis on cancer research. Tumori. 1990;76(1):1-9
Boracchi, P., Mezzanotte, G., Mariani, L., Valagussa, P., & Marubini, E. (1990). Clinically useful measures to assess the effectiveness of treatments: hints for a proper choice with special emphasis on cancer research. Tumori, 76(1), 1-9.
Boracchi, P, et al. "Clinically useful measures to assess the effectiveness of treatments: hints for a proper choice with special emphasis on cancer research." Tumori vol. 76,1 (1990): 1-9.
Boracchi P, Mezzanotte G, Mariani L, Valagussa P, Marubini E. Clinically useful measures to assess the effectiveness of treatments: hints for a proper choice with special emphasis on cancer research. Tumori. 1990 Feb 28;76(1):1-9. PMID: 2321266.
Copy Download .nbib Format: NLM
The influential and inspirational Gianni Bonadonna's life commitment to evidence-based cancer medicine.

Annals of oncology : official journal of the European Society for Medical Oncology

Curigliano G, Valagussa P, Veronesi U, Gianni L.
PMID: 26598541
Ann Oncol. 2016 Jan;27(1):6-8. doi: 10.1093/annonc/mdv565. Epub 2015 Nov 23.

No abstract available.

Cite
Curigliano G, Valagussa P, Veronesi U, et al. The influential and inspirational Gianni Bonadonna's life commitment to evidence-based cancer medicine. Ann Oncol. 2015;27(1):6-8doi: 10.1093/annonc/mdv565.
Curigliano, G., Valagussa, P., Veronesi, U., & Gianni, L. (2016). The influential and inspirational Gianni Bonadonna's life commitment to evidence-based cancer medicine. Annals of oncology : official journal of the European Society for Medical Oncology, 27(1), 6-8. https://doi.org/10.1093/annonc/mdv565
Curigliano, G, et al. "The influential and inspirational Gianni Bonadonna's life commitment to evidence-based cancer medicine." Annals of oncology : official journal of the European Society for Medical Oncology vol. 27,1 (2016): 6-8. doi: https://doi.org/10.1093/annonc/mdv565
Curigliano G, Valagussa P, Veronesi U, Gianni L. The influential and inspirational Gianni Bonadonna's life commitment to evidence-based cancer medicine. Ann Oncol. 2016 Jan;27(1):6-8. doi: 10.1093/annonc/mdv565. Epub 2015 Nov 23. PMID: 26598541.
Copy Download .nbib Format: NLM
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer.

NPJ breast cancer

Gianni L, Colleoni M, Bisagni G, Mansutti M, Zamagni C, Del Mastro L, Zambelli S, Bianchini G, Frassoldati A, Maffeis I, Valagussa P, Viale G.
PMID: 35013314
NPJ Breast Cancer. 2022 Jan 10;8(1):1. doi: 10.1038/s41523-021-00377-8.

The crosstalk between estrogen and HER2 receptors and cell-cycle regulation sustains resistance to endocrine therapy of HER2- and hormone receptor-positive breast cancer. We earlier reported that women with HER2 and ER-positive breast cancer receiving neoadjuvant dual HER2-block and palbociclib...

Cite
Gianni L, Colleoni M, Bisagni G, et al. Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer. NPJ Breast Cancer. 2022;8(1):1doi: 10.1038/s41523-021-00377-8.
Gianni, L., Colleoni, M., Bisagni, G., Mansutti, M., Zamagni, C., Del Mastro, L., Zambelli, S., Bianchini, G., Frassoldati, A., Maffeis, I., Valagussa, P., & Viale, G. (2022). Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer. NPJ breast cancer, 8(1), 1. https://doi.org/10.1038/s41523-021-00377-8
Gianni, Luca, et al. "Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer." NPJ breast cancer vol. 8,1 (2022): 1. doi: https://doi.org/10.1038/s41523-021-00377-8
Gianni L, Colleoni M, Bisagni G, Mansutti M, Zamagni C, Del Mastro L, Zambelli S, Bianchini G, Frassoldati A, Maffeis I, Valagussa P, Viale G. Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer. NPJ Breast Cancer. 2022 Jan 10;8(1):1. doi: 10.1038/s41523-021-00377-8. PMID: 35013314.
Copy Download .nbib Format: NLM
Sequential Adriamycin and CMF in Metastatic Breast Cancer.

The oncologist

Zambetti M, Giacobone A, Terenziani M, Zucchinelli P, Demicheli R, Biasi S, Piotti P, Bartoli C, Valagussa P, Bonadonna G.
PMID: 10388053
Oncologist. 1997;2(4):223-227.

PURPOSE: To evaluate the clinical activity of a sequential treatment with Adriamycin followed by CMF (cyclophosphamide, methotrexate, fluorouracil) and the relative therapeutic contribution of the two drug regimens given at full conventional doses in metastatic breast cancer. PATIENTS AND...

Cite
Zambetti M, Giacobone A, Terenziani M, et al. Sequential Adriamycin and CMF in Metastatic Breast Cancer. Oncologist. 1997;2(4):223-227
Zambetti, M., Giacobone, A., Terenziani, M., Zucchinelli, P., Demicheli, R., Biasi, S., Piotti, P., Bartoli, C., Valagussa, P., & Bonadonna, G. (1997). Sequential Adriamycin and CMF in Metastatic Breast Cancer. The oncologist, 2(4), 223-227.
Zambetti, et al. "Sequential Adriamycin and CMF in Metastatic Breast Cancer." The oncologist vol. 2,4 (1997): 223-227.
Zambetti M, Giacobone A, Terenziani M, Zucchinelli P, Demicheli R, Biasi S, Piotti P, Bartoli C, Valagussa P, Bonadonna G. Sequential Adriamycin and CMF in Metastatic Breast Cancer. Oncologist. 1997;2(4):223-227. PMID: 10388053.
Copy Download .nbib Format: NLM
Physiological Profile Assessment of Posture in Children and Adolescents with Autism Spectrum Disorder and Typically Developing Peers.

Brain sciences

Perin C, Valagussa G, Mazzucchelli M, Gariboldi V, Cerri CG, Meroni R, Grossi E, Cornaggia CM, Menant J, Piscitelli D.
PMID: 32992546
Brain Sci. 2020 Sep 27;10(10). doi: 10.3390/brainsci10100681.

A sound postural system requires sensorimotor integration. Evidence suggests that individuals with Autism Spectrum Disorder (ASD) present sensorimotor integration impairments. The Physiological Profile Assessment (PPA) can be used to evaluate postural capacity assessing five physiological subsets (i.e., vision, reaction...

Cite
Perin C, Valagussa G, Mazzucchelli M, et al. Physiological Profile Assessment of Posture in Children and Adolescents with Autism Spectrum Disorder and Typically Developing Peers. Brain Sci. 2020;10(10)doi: 10.3390/brainsci10100681.
Perin, C., Valagussa, G., Mazzucchelli, M., Gariboldi, V., Cerri, C. G., Meroni, R., Grossi, E., Cornaggia, C. M., Menant, J., & Piscitelli, D. (2020). Physiological Profile Assessment of Posture in Children and Adolescents with Autism Spectrum Disorder and Typically Developing Peers. Brain sciences, 10(10), . https://doi.org/10.3390/brainsci10100681
Perin, Cecilia, et al. "Physiological Profile Assessment of Posture in Children and Adolescents with Autism Spectrum Disorder and Typically Developing Peers." Brain sciences vol. 10,10 (2020). doi: https://doi.org/10.3390/brainsci10100681
Perin C, Valagussa G, Mazzucchelli M, Gariboldi V, Cerri CG, Meroni R, Grossi E, Cornaggia CM, Menant J, Piscitelli D. Physiological Profile Assessment of Posture in Children and Adolescents with Autism Spectrum Disorder and Typically Developing Peers. Brain Sci. 2020 Sep 27;10(10). doi: 10.3390/brainsci10100681. PMID: 32992546; PMCID: PMC7601261.
Copy Download .nbib Format: NLM
Relationship between tip-toe behavior and soleus - gastrocnemius muscle lengths in individuals with autism spectrum disorders.

Journal of orthopaedics

Valagussa G, Balatti V, Trentin L, Piscitelli D, Yamagata M, Grossi E.
PMID: 32982098
J Orthop. 2020 Aug 20;21:444-448. doi: 10.1016/j.jor.2020.08.013. eCollection 2020.

BACKGROUND: About 20% of individuals with autism spectrum disorders (ASD) showed tip-toe behavior (TTB). This behavior may be related to a decreased ankle joint range of motion (ROM) in dorsiflexion. Physiologically, gastrocnemius (GM) and soleus (SM) muscles influence ankle...

Cite
Valagussa G, Balatti V, Trentin L, et al. Relationship between tip-toe behavior and soleus - gastrocnemius muscle lengths in individuals with autism spectrum disorders. J Orthop. 2020;21:444-448doi: 10.1016/j.jor.2020.08.013.
Valagussa, G., Balatti, V., Trentin, L., Piscitelli, D., Yamagata, M., & Grossi, E. (2020). Relationship between tip-toe behavior and soleus - gastrocnemius muscle lengths in individuals with autism spectrum disorders. Journal of orthopaedics, 21444-448. https://doi.org/10.1016/j.jor.2020.08.013
Valagussa, Giulio, et al. "Relationship between tip-toe behavior and soleus - gastrocnemius muscle lengths in individuals with autism spectrum disorders." Journal of orthopaedics vol. 21 (2020): 444-448. doi: https://doi.org/10.1016/j.jor.2020.08.013
Valagussa G, Balatti V, Trentin L, Piscitelli D, Yamagata M, Grossi E. Relationship between tip-toe behavior and soleus - gastrocnemius muscle lengths in individuals with autism spectrum disorders. J Orthop. 2020 Aug 20;21:444-448. doi: 10.1016/j.jor.2020.08.013. eCollection 2020. PMID: 32982098; PMCID: PMC7493131.
Copy Download .nbib Format: NLM
Patterns of Restricted and Repetitive Behaviors in Autism Spectrum Disorders: A Cross-Sectional Video Recording Study. Preliminary Report.

Brain sciences

Grossi E, Caminada E, Goffredo M, Vescovo B, Castrignano T, Piscitelli D, Valagussa G, Franceschini M, Vanzulli F.
PMID: 34064245
Brain Sci. 2021 May 21;11(6). doi: 10.3390/brainsci11060678.

BACKGROUND: Several instruments have been proposed to investigate restricted, repetitive behaviors (RRBs) in individuals with Autism Spectrum Disorder (ASD). Systematic video observations may overcome questionnaire and interview limitations to investigate RRBs. This study aimed to analyze stereotypic patterns through...

Cite
Grossi E, Caminada E, Goffredo M, et al. Patterns of Restricted and Repetitive Behaviors in Autism Spectrum Disorders: A Cross-Sectional Video Recording Study. Preliminary Report. Brain Sci. 2021;11(6)doi: 10.3390/brainsci11060678.
Grossi, E., Caminada, E., Goffredo, M., Vescovo, B., Castrignano, T., Piscitelli, D., Valagussa, G., Franceschini, M., & Vanzulli, F. (2021). Patterns of Restricted and Repetitive Behaviors in Autism Spectrum Disorders: A Cross-Sectional Video Recording Study. Preliminary Report. Brain sciences, 11(6), . https://doi.org/10.3390/brainsci11060678
Grossi, Enzo, et al. "Patterns of Restricted and Repetitive Behaviors in Autism Spectrum Disorders: A Cross-Sectional Video Recording Study. Preliminary Report." Brain sciences vol. 11,6 (2021). doi: https://doi.org/10.3390/brainsci11060678
Grossi E, Caminada E, Goffredo M, Vescovo B, Castrignano T, Piscitelli D, Valagussa G, Franceschini M, Vanzulli F. Patterns of Restricted and Repetitive Behaviors in Autism Spectrum Disorders: A Cross-Sectional Video Recording Study. Preliminary Report. Brain Sci. 2021 May 21;11(6). doi: 10.3390/brainsci11060678. PMID: 34064245; PMCID: PMC8224357.
Copy Download .nbib Format: NLM
Role of landslides on the volume balance of the Nepal 2015 earthquake sequence.

Scientific reports

Valagussa A, Frattini P, Valbuzzi E, Crosta GB.
PMID: 33564079
Sci Rep. 2021 Feb 09;11(1):3434. doi: 10.1038/s41598-021-83037-y.

The 7.8 M

Cite
Valagussa A, Frattini P, Valbuzzi E, et al. Role of landslides on the volume balance of the Nepal 2015 earthquake sequence. Sci Rep. 2021;11(1):3434doi: 10.1038/s41598-021-83037-y.
Valagussa, A., Frattini, P., Valbuzzi, E., & Crosta, G. B. (2021). Role of landslides on the volume balance of the Nepal 2015 earthquake sequence. Scientific reports, 11(1), 3434. https://doi.org/10.1038/s41598-021-83037-y
Valagussa, A, et al. "Role of landslides on the volume balance of the Nepal 2015 earthquake sequence." Scientific reports vol. 11,1 (2021): 3434. doi: https://doi.org/10.1038/s41598-021-83037-y
Valagussa A, Frattini P, Valbuzzi E, Crosta GB. Role of landslides on the volume balance of the Nepal 2015 earthquake sequence. Sci Rep. 2021 Feb 09;11(1):3434. doi: 10.1038/s41598-021-83037-y. PMID: 33564079; PMCID: PMC7873231.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries